Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 10, 2014, Pages 3429-3438

  Shui, Wei ^a   Zhang, Wenwen ^a,b   Yin, Liangjun ^a,b   Nan, Guoxin ^a,b   Liao, Zhan ^b,c   Zhang, Hongmei ^a,b   Wang, Ning ^b,d   Wu, Ningning ^a,b   Chen, Xian ^a,b   Wen, Sheng ^a,b   He, Yunfeng ^a,b   Deng, Fang ^b,d   Zhang, Junhui ^a,b   Luu, Hue H ^b   Shi, Lewis L ^b   Hu, Zhenming ^a   Haydon, Rex C ^b,d   Mok, James M ^b   He, Tong Chuan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

BMP9; bone formation; bone regeneration; bone tissue engineering; cell based therapy; scaffold carriers

Indexed keywords

BIOCOMPATIBILITY; BONE; CELLS; CHARACTERIZATION; COLLAGEN; CYTOLOGY;

BMP9; BONE FORMATION; BONE REGENERATION; BONE TISSUE ENGINEERING; CELL-BASED THERAPY;

SCAFFOLDS (BIOLOGY);

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 9; CALCIUM PHOSPHATE; COLLAGEN SPONGE; COLLAGEN TYPE 1; HYDROXYAPATITE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE MATRIX; BONE REGENERATION; BONE TISSUE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; STEM CELL GENE THERAPY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRABECULAR BONE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BONE DEVELOPMENT; CHEMISTRY; CHORISTOMA; CYTOLOGY; DRUG EFFECTS; GENETIC TRANSDUCTION; HEK293 CELL LINE; MALE; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PATHOLOGY; STEM CELL;

ANIMALS; BONE REGENERATION; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CHORISTOMA; COLLAGEN TYPE I; DURAPATITE; GROWTH DIFFERENTIATION FACTOR 2; HEK293 CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE, NUDE; OSTEOBLASTS; OSTEOGENESIS; STEM CELLS; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC;

EID: 84906781284     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35006     Document Type: Article

References (57)

1. Luo J, Sun MH, Kang Q, Peng Y, Jiang W, Luu HH, Luo Q, Park JY, Li Y, Haydon RC, He TC,. Gene therapy for bone regeneration. Curr Gene Ther 2005; 5: 167-179.
2. Luther G, Wagner ER, Zhu G, Kang Q, Luo Q, Lamplot J, Bi Y, Luo X, Luo J, Teven C, Shi Q, Kim SH, Gao JL, Huang E, Yang K, Rames R, Liu X, Li M, Hu N, Liu H, Su Y, Chen L, He BC, Zuo GW, Deng ZL, Reid RR, Luu HH, Haydon RC, He TC,. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: Molecular mechanism and therapeutic potential. Curr Gene Ther 2011; 11: 229-240.
3. Lamplot JD, Qin J, Nan G, Wang J, Liu X, Yin L, Tomal J, Li R, Shui W, Zhang H, Kim SH, Zhang W, Zhang J, Kong Y, Denduluri S, Rogers MR, Pratt A, Haydon RC, Luu HH, Angeles J, Shi LL, He TC,. BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells 2013; 2: 1-21.
4. Ishihara A, Bertone AL,. Cell-mediated and direct gene therapy for bone regeneration. Expert Opin Biol Ther 2012; 12: 411-423.
5. Kimelman Bleich N, Kallai I, Lieberman JR, Schwarz EM, Pelled G, Gazit D,. Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev 2012; 64: 1320-1330.
6. Wilson CG, Martin-Saavedra FM, Vilaboa N, Franceschi RT,. Advanced BMP gene therapies for temporal and spatial control of bone regeneration. J Dent Res 2013; 92: 409-417.
7. Olsen BR, Reginato AM, Wang W,. Bone development. Annu Rev Cell Dev Biol 2000; 16: 191-220.
8. Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC,. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2: 67-80.
9. Prockop DJ,. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
11. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, Xue A, Montag AG, Luu HH, Haydon RC, He TC,. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008; 13: 2001-2021.
12. Chimutengwende-Gordon M, Khan WS,. Advances in the use of stem cells and tissue engineering applications in bone repair. Curr Stem Cell Res Ther 2012; 7: 122-126.
13. Shi Y, Massague J,. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700.
14. Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC, He TC,. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 2007; 25: 665-677.
15. Varga AC, Wrana JL,. The disparate role of BMP in stem cell biology. Oncogene 2005; 24: 5713-5721.
16. Zhang J, Li L,. BMP signaling and stem cell regulation. Dev Biol 2005; 284: 1-11.
17. Hogan BL,. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-1594.
18. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC,. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85: 1544-1552.
19. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He TC,. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11: 1312-1320.
20. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC, He TC,. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 2003; 90: 1149-1165.
21. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, Luu HH, Park JK, Li X, Luo J, Montag AG, Haydon RC, He TC,. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 32941-32949.
22. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC,. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 55958-55968.
23. Sharff KA, Song WX, Luo X, Tang N, Luo J, Chen J, Bi Y, He BC, Huang J, Li X, Jiang W, Zhu GH, Su Y, He Y, Shen J, Wang Y, Chen L, Zuo GW, Liu B, Pan X, Reid RR, Luu HH, Haydon RC, He TC,. Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem 2009; 284: 649-659.
24. Tang N, Song WX, Luo J, Luo X, Chen J, Sharff KA, Bi Y, He BC, Huang JY, Zhu GH, Su YX, Jiang W, Tang M, He Y, Wang Y, Chen L, Zuo GW, Shen J, Pan X, Reid RR, Luu HH, Haydon RC, He TC,. BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med 2009; 13: 2448-2464.
25. Song JJ, Celeste AJ, Kong FM, Jirtle RL, Rosen V, Thies RS,. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 1995; 136: 4293-4297.
26. Huang E, Zhu G, Jiang W, Yang K, Gao Y, Luo Q, Gao JL, Kim SH, Liu X, Li M, Shi Q, Hu N, Wang L, Liu H, Cui J, Zhang W, Li R, Chen X, Kong YH, Zhang J, Wang J, Shen J, Bi Y, Statz J, He BC, Luo J, Wang H, Xiong F, Luu HH, Haydon RC, Yang L, He TC,. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Miner Res 2012; 27: 1566-1575.
27. Chen L, Jiang W, Huang J, He BC, Zuo GW, Zhang W, Luo Q, Shi Q, Zhang BQ, Wagner ER, Luo J, Tang M, Wietholt C, Luo X, Bi Y, Su Y, Liu B, Kim SH, He CJ, Hu Y, Shen J, Rastegar F, Huang E, Gao Y, Gao JL, Zhou JZ, Reid RR, Luu HH, Haydon RC, He TC, Deng ZL,. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 2010; 25: 2447-2459.
28. Hu N, Jiang D, Huang E, Liu X, Li R, Liang X, Kim SH, Chen X, Gao JL, Zhang H, Zhang W, Kong YH, Zhang J, Wang J, Shui W, Luo X, Liu B, Cui J, Rogers MR, Shen J, Zhao C, Wang N, Wu N, Luu HH, Haydon RC, He TC, Huang W,. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci 2013; 126: 532-541.
29. Liu X, Qin J, Luo Q, Bi Y, Zhu G, Jiang W, Kim SH, Li M, Su Y, Nan G, Cui J, Zhang W, Li R, Chen X, Kong Y, Zhang J, Wang J, Rogers MR, Zhang H, Shui W, Zhao C, Wang N, Liang X, Wu N, He Y, Luu HH, Haydon RC, Shi LL, Li T, He TC, Li M,. Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med 2013. doi: 10.1111/jcmm.12097.
30. Kim JH, Liu X, Wang J, Chen X, Zhang H, Kim SH, Cui J, Li R, Zhang W, Kong Y, Zhang J, Shui W, Lamplot J, Rogers MR, Zhao C, Wang N, Rajan P, Tomal J, Statz J, Wu N, Luu HH, Haydon RC, He TC,. Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis 2013; 5: 13-31.
31. Wang Y, Hong S, Li M, Zhang J, Bi Y, He Y, Liu X, Nan G, Su Y, Zhu G, Li R, Zhang W, Wang J, Zhang H, Kong Y, Shui W, Wu N, He Y, Chen X, Luu HH, Haydon RC, Shi LL, He TC, Qin J,. Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res 2013; 31: 1796-1803.
32. Luo X, Chen J, Song WX, Tang N, Luo J, Deng ZL, Sharff KA, He G, Bi Y, He BC, Bennett E, Huang J, Kang Q, Jiang W, Su Y, Zhu GH, Yin H, He Y, Wang Y, Souris JS, Chen L, Zuo GW, Montag AG, Reid RR, Haydon RC, Luu HH, He TC,. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 2008; 88: 1264-1277.
33. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B,. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
34. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC,. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007; 2: 1236-1247.
35. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW,. Identification of c-MYC as a target of the APC pathway [see comments]. Science 1998; 281: 1509-1512.
36. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC,. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 2006; 26: 2955-2964.
37. Kang Q, Song WX, Luo Q, Tang N, Luo J, Luo X, Chen J, Bi Y, He BC, Park JK, Jiang W, Tang Y, Huang J, Su Y, Zhu GH, He Y, Yin H, Hu Z, Wang Y, Chen L, Zuo GW, Pan X, Shen J, Vokes T, Reid RR, Haydon RC, Luu HH, He TC,. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18: 545-559.
38. Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q, Shi Q, Zhang BQ, Wagner ER, Rastegar F, Kim SH, Jiang W, Shen J, Huang E, Gao Y, Gao JL, Zhou JZ, Luo J, Huang J, Luo X, Bi Y, Su Y, Yang K, Liu H, Luu HH, Haydon RC, He TC, He BC,. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 2010; 5: e11917.
39. Huang J, Bi Y, Zhu GH, He Y, Su Y, He BC, Wang Y, Kang Q, Chen L, Zuo GW, Luo Q, Shi Q, Zhang BQ, Huang A, Zhou L, Feng T, Luu HH, Haydon RC, He TC, Tang N,. Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int 2009; 29: 1569-1581.
40. Zhu GH, Huang J, Bi Y, Su Y, Tang Y, He BC, He Y, Luo J, Wang Y, Chen L, Zuo GW, Jiang W, Luo Q, Shen J, Liu B, Zhang WL, Shi Q, Zhang BQ, Kang Q, Zhu J, Tian J, Luu HH, Haydon RC, Chen Y, He TC,. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 2009; 78: 195-204.
41. Rastegar F, Gao JL, Shenaq D, Luo Q, Shi Q, Kim SH, Jiang W, Wagner ER, Huang E, Gao Y, Shen J, Yang K, He BC, Chen L, Zuo GW, Luo J, Luo X, Bi Y, Liu X, Li M, Hu N, Wang L, Luther G, Luu HH, Haydon RC, He TC,. Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PLoS One 2010; 5: e14182.
42. Su Y, Wagner ER, Luo Q, Huang J, Chen L, He BC, Zuo GW, Shi Q, Zhang BQ, Zhu G, Bi Y, Luo J, Luo X, Kim SH, Shen J, Rastegar F, Huang E, Gao Y, Gao JL, Yang K, Wietholt C, Li M, Qin J, Haydon RC, He TC, Luu HH,. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 2011; 30: 3907-3917.
43. Luo J, Tang M, Huang J, He BC, Gao JL, Chen L, Zuo GW, Zhang W, Luo Q, Shi Q, Zhang BQ, Bi Y, Luo X, Jiang W, Su Y, Shen J, Kim SH, Huang E, Gao Y, Zhou JZ, Yang K, Luu HH, Pan X, Haydon RC, Deng ZL, He TC,. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem 2010; 285: 29588-29598.
44. Huang E, Bi Y, Jiang W, Luo X, Yang K, Gao JL, Gao Y, Luo Q, Shi Q, Kim SH, Liu X, Li M, Hu N, Liu H, Cui J, Zhang W, Li R, Chen X, Shen J, Kong Y, Zhang J, Wang J, Luo J, He BC, Wang H, Reid RR, Luu HH, Haydon RC, Yang L, He TC,. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One 2012; 7: e32428.
45. Seeherman H, Wozney J, Li R,. Bone morphogenetic protein delivery systems. Spine 2002; 27: S16-S23.
46. Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T,. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001; 26: 933-939.
47. Suh DY, Boden SD, Louis-Ugbo J, Mayr M, Murakami H, Kim HS, Minamide A, Hutton WC,. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine (Phila Pa 1976) 2002; 27: 353-360.
48. Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO,. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 2002; 292: 144-152.
49. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman JR,. Effect of regional gene therapy with bone morphogenetic protein-2- producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am 2003; 85: 905-911.
50. Boden SD, Martin GJ, Jr, Morone M, Ugbo JL, Titus L, Hutton WC,. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 1999; 24: 320-327.
51. Yee AJ, Bae HW, Friess D, Robbin M, Johnstone B, Yoo JU,. Augmentation of rabbit posterolateral spondylodesis using a novel demineralized bone matrix-hyaluronan putty. Spine (Phila Pa 1976) 2003; 28: 2435-2440.
52. Wang JC, Kanim LE, Nagakawa IS, Yamane BH, Vinters HV, Dawson EG,. Dose-dependent toxicity of a commercially available demineralized bone matrix material. Spine (Phila Pa 1976) 2001; 26: 1429-1435; discussion 1436.
53. Porter JR, Ruckh TT, Popat KC,. Bone tissue engineering: A review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009; 25: 1539-1560.
54. Szpalski C, Wetterau M, Barr J, Warren SM,. Bone tissue engineering: Current strategies and techniques-Part I: Scaffolds. Tissue Eng Part B Rev 2012; 18: 246-257.
55. Demirkiran H,. Bioceramics for osteogenesis, molecular and cellular advances. Adv Exp Med Biol 2012; 760: 134-147.
56. Holzwarth JM, Ma PX,. Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 2011; 32: 9622-9629.
57. Scott TG, Blackburn G, Ashley M, Bayer IS, Ghosh A, Biris AS, Biswas A,. Advances in bionanomaterials for bone tissue engineering. J Nanosci Nanotechnol 2013; 13: 1-22.